Skip to content
  • Insights Newsletter

    Always Be a Step Ahead

    Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

    Subscribe to AMI's Insights Newsletter Today.

     

  • Login
  • Contact
  • Subscribe
  • Insights Newsletter

    Always Be a Step Ahead

    Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

    Subscribe to AMI's Insights Newsletter Today.

     

  • Login
Access Market IntelligenceAccess Market Intelligence
  • Menu
  • About
    • Dr. Randy Vogenberg
    • John Santilli
    • News Announcements
    • Contact
  • Shop Reports
    • Filter By
      • Discounted
      • Latest Releases
    • Report Topic or Type
      • Ebooks
      • Provider Trends
      • Payor Trends
      • Purchaser Trends
      • Market Access & Distribution
  • Solutions
    • Data and Intelligence Platforms
      • Employer Sales Initiatives
    • Advisory and Consulting Services
      • Virtual Advisory Board for Healthcare
      • Strategy Development
      • Health Benefit Training
      • Custom Market Research
    • Specialty Pharmacy Database
  • Resources
    • Insights Blog
    • Sample Reports
    • Free Publications
  • Specialty Pharmacy Database
    • Blog – Specialty Pharmacy
    • SPD Case Study
    • SPD Request for Information
  • $0.00 0
    • No products in the cart.

  • Shop
  • 0

    Cart

    No products in the cart.

Tag Archives: Apealea

Specialty Drug, Specialty Pharmacy

Tanner Pharma Group Increasing Product Access With Named Patient Programs

Posted on October 6, 2020 by John Santilli
06
Oct

A Named Patient Program (NPP) provides patients and physicians access to commercially approved medicines that are not available to them in their own country

Continue reading →
Posted in Specialty Drug, Specialty Pharmacy  |  Tagged AndroFeme, Apealea, Australia, bioanalysis, biotech, clinical trial, commercialize, Dompe, Elevar Therapeutics, Europe, global access, Lawley Pharmaceuticals, license, market access, Named Patient Program, NPP, Oxervate, pharmaceutical, pharmaceutical services, Tanner, Tanner Pharma, Tanner Pharma Group, Tasman Pharma, Versacloz

Copyright 2023 © Access Market Intelligence. All Rights Reserved  |  Terms of Service 

  • Login
  • Home
  • Reports
    • View Samples
    • What’s New
    • On Sale
    • eBooks
    • By Market
      • Payor
      • Purchaser
      • Provider
      • Market Access & Distribution
  • Services
    • Virtual Advisory Board
    • Strategy Development
    • Health Benefit Training
    • Market Research
  • Data Solutions
    • Specialty Pharmacy Database (SPD)
    • Employer Sales Initiatives
  • Resources
    • Blog
    • Free Downloads
  • About
    • Contact

Login

Lost your password?

Register